. . . . . . . "[In the future, application of more refined clinical criteria, as well as expected improvements in laboratory techniques, will undoubtedly lead to significantly better outcomes and options in surveillance and management for hereditary breast and ovarian cancer syndromes caused by mutations of BRCA1 and BRCA2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:11:01+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .